CD86 and neoplasm: In the model, T cell activation occurs through the binding of TCR/CD3 complex to major histocompatibility complex (MHC) on APCs and tumor cells, accompanied by the physical interaction between CD80/CD86 on APCs and CD28 on T cells (Boomer and Green, 2010; Bommhardt et al., 2019).